Cyclo Therapeutics Inc (CYTH)

[Cloner2]

I think I bought some of your shares. The potential value of this company is in the treatment of atherosclerosis. If it is approved, then it will likely be used as an off label treatment for atherosclerosis because it is cheap, and has no real toxicity issues. And then you are talking about big bucks.

https://www.sciencedaily.com/releases/2016/04/160406165248.htm

Why else would they be building a facility for 51 employees in Jupiter Florida at an average cost of 71,000 per employee? That is three times their current earnings!

I still think it is very much a gamble and I have agonized over whether or not I should buy more shares. They have to get enough people into their clinical trial and show efficacy and there are only something like 500 people world wide with Niemann Pick C.


I am a research scientists so I have also read most of the related papers. I have never done this much research on a company.